alexa Combining Multi-parametric MRI (mpMRI), MR-ultrasound Fusion Biopsy, And High Intensity Focused Ultrasound (HIFU): A Winning Team In The Fight Against Organ Confined Prostate Cancer
ISSN: 1948-5956

Journal of Cancer Science & Therapy
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

JOINT EVENT:19th Euro Congress on Cancer Science and Therapy & 25th Cancer Nursing & Nurse Practitioners Conference
July 17-19, 2017 Lisbon, Portugal

Les Bentz
Vituro Health, USA
Posters & Accepted Abstracts: J Cancer Sci Ther
DOI: 10.4172/1948-5956-C1-106
Abstract
HIFU, a minimally invasive ablative therapy, has been used as an effective tool against organ confined prostate cancer for over a decade around the globe with efficacy results comparable to radical prostatectomy and radiation therapy but with the benefit to patients of much lower rates of erectile dis-function and incontinence. Due to the precise nature of HIFU, real time ultrasound imaging and the ability to modulate power for each HIFU energy pulse, the structures controlling erections and urinary continence can be avoided affording the patient better outcomes than other treatment options. Initially, HIFU was used for total gland ablation, but recently has shifted to a more focal approach due to the convergence of mpMRI and HIFU technologies. The mpMRI has excellent sensitivity in identifying clinically significant cancer tissue in the prostate with the added benefit that it is more sensitive detecting aggressive cancer tissue than clinically insignificant cancers. Exporting the information generated from the mpMRI to an MRUltrasound fusion biopsy device, a precisely targeted fusion biopsy can be performed with pinpoint accuracy and repeatability to sample suspicious tissue greatly reducing false negative biopsies and providing more accurate cancer staging information than that obtained from traditional sextant biopsies. With the best possible diagnostic data, the MR information can again be exported, this time to the HIFU therapeutic device, for fusion with live ultrasound images during ablative therapy to precisely target and destroy only the cancerous tissues with even less impact to the surrounding structures, generating outstanding patient outcomes equating to better post treatment quality of life. Patients today are being diagnosed with prostate cancer at earlier ages and this winning team of technologies provides good efficacy, is truly minimally, and delivers the patient an exceptional quality of life.
Biography

Email: [email protected]

image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords